Transforming CTMS: An Operating Layer for Real-Time Trial Execution
CTMS platforms do not lack capability. They reflect an earlier architectural priority.
Patient Responsibility Is Rising — The Payment Experience Needs to Keep Up
Payment friction isn't always obvious. It shows up in extended accounts receivable timelines, increased billing inquiries, and patients who delay payment – not because they're unwilling to pay, but because the process made it harder than it needed to be.
Lack of Trust, Not Technology, is What’s Stopping Health Plans from Meeting Their Mission and Financial Objectives
Healthcare often expects consumers to contort themselves around processes that were never built with them in mind — and that’s where the trust issue begins. With the looming arrival of HR1, how to fix it.
How PE Is Adjusting Its Healthcare Playbook Now that It’s Under the Microscope
Lawmakers are applying increased scrutiny to private equity’s involvement in healthcare, particularly when it comes to physician practice roll-ups. But investor Matthew Bennett argues the pressure is reshaping rather than shrinking the sector, pushing firms away from roll-ups and toward strategies focused on improving outcomes and using technology to boost efficiency.
Bayer Sees Opportunity With $300M Acquisition of Eye Drug Biotech
Perfuse Therapeutics brings Bayer an eye drug administered via an implant that controls the release of the therapy. This program is in mid-stage clinical development for glaucoma and diabetic retinopathy.